EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

YK-4-279 Induces Osteosarcoma Cell Cycle Arrest, DNA Damage Response, and Apoptosis by Regulating the MAPK Cascade

Weifeng Wang, Yuli Zhang iD, Xiuqin Jia iD, Liren Han, Ming Xin iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s542983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Weifeng Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Beijing Jishuitan Hospital Liaocheng Hospital, Liaocheng, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: Osteosarcoma, Apoptosis, DNA Damage, Bone Neoplasms. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaApoptosisDNA DamageBone NeoplasmsCell Cycle CheckpointsAntineoplastic AgentsMAP Kinase Signaling SystemHumansCell ProliferationCell SurvivalDrug Screening Assays, AntitumorDose-Response Relationship, DrugTumor Cells, CulturedStructure-Activity RelationshipCell Line, TumorMolecular Structure

Stichwörter der Autor:innen

DNA damageMAPK signaling pathwayYK-4-279apoptosiscell cycleosteosarcoma

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Beijing Jishuitan Hospital Liaocheng Hospital, Liaocheng, Shandong, People's Republic of China.
  • Department of Orthopedic Surgery, Liaocheng People's Hospital, Liaocheng, Shandong, People's Republic of China.
  • School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.
  • Department of Dermatology, Liaocheng People's Hospital, Liaocheng, Shandong, People's Republic of China.
  • Department of Dermatology, The Second Hospital of Shandong University, Jinan, Shandong, People's Republic of China.
  • The Key Laboratory of Clinical Pharmacology, Liaocheng People's Hospital, Liaocheng, Shandong, People's Republic of China.

ORCID-Profile: Yuli Zhang, Xiuqin Jia, Ming Xin

Zitieren

APA

Wang, W., Zhang, Y., Jia, X., Han, L., & Xin, M. (2025). YK-4-279 Induces Osteosarcoma Cell Cycle Arrest, DNA Damage Response, and Apoptosis by Regulating the MAPK Cascade. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s542983

Vancouver

Wang W, Zhang Y, Jia X, Han L, Xin M. YK-4-279 Induces Osteosarcoma Cell Cycle Arrest, DNA Damage Response, and Apoptosis by Regulating the MAPK Cascade. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s542983

BibTeX
@article{Wang2025,
  author = {Wang, Weifeng and Zhang, Yuli and Jia, Xiuqin and Han, Liren and Xin, Ming},
  title = {YK-4-279 Induces Osteosarcoma Cell Cycle Arrest, DNA Damage Response, and Apoptosis by Regulating the MAPK Cascade},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s542983}
}
Kostenlos starten →